If you need more lookups,
subscriptions start at $34 USD/month.
Federica Pericle Location
Houston, TX, US
Federica Pericle Work
Chief Scientific Officer @ (April 2024 - Present)
Acting Chief Scientific Officer @ (December 2020 - March 2024)
Scientific Analyst @ (May 2007 - Present)
Strategic Advisor @ (March 2020 - March 2022)
President and CEO @ AgilVax (March 2013 - August 2019)
Associate VP for Biotechnology @ (August 2006 - June 2015)
Co-Founder, COO and BOD Member @ Senexta Therapeutics SA (November 2008 - December 2012)
Scientific Advisor @ Agennix (August 2002 - August 2012)
Founder, CEO and Chairman @ EP Pharma (November 2008 - January 2012)
Director, Oncology Program @ GeneMedicine/Valentis (January 1997 - January 2002)
Federica Pericle Education
Texas A&M University
Master of Business Administration (MBA)
2001-2003
Università degli Studi di Torino
PhD
1988-1992
Federica Pericle Skills
Antibodies
Biochemistry
Biopharmaceuticals
Biotechnology
Cell Biology
Cell Culture
Clinical Development
Clinical Trials
Clinics
Drug Development
Drug Discovery
Immunology
Infectious Diseases
Life Sciences
Lifesciences
Molecular Biology
Oncology
Pharmaceutical Industry
Startups
Technology Transfer
Therapeutics
Vaccines
Marketing
IP
Public Speaking
Project Management
Microsoft Excel
Business Strategy
Federica Pericle Summary
Federica Pericle, based in Houston, TX, US, is currently a Chief Scientific Officer at ImmunoGenesis, Inc.. Federica Pericle brings experience from previous roles at ImmunoGenesis, Inc., BlueStar Investment Managers SA, Chrysalis BioTherapeutics, Inc. and AgilVax. Federica Pericle holds a 2001 - 2003 Master of Business Administration (MBA) @ Texas A&M University. With a robust skill set that includes Antibodies, Biochemistry, Biopharmaceuticals, Biotechnology, Cell Biology and more. Federica Pericle has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Federica Pericle?
Find contact details for 700 million professionals.